Postoperative Cancer Surveillance Following Oncoplastic Surgery with Latissimus Dorsi Flap: a Matched Case–Control Study

  • Kenneth L. Fan
  • Simon Yang
  • Seho Park
  • Tae Hwan Park
  • Seung Yong Song
  • Nara Lee
  • Dae Hyun Lew
  • Min Jung KimEmail author
  • Dong Won LeeEmail author
Reconstructive Oncology



The latissimus dorsi (LD) myocutaneous flap is a widely used local option in oncoplastic surgery for avoiding breast deformities; however, concerns exist regarding its influence in monitoring recurrence. In this study, we evaluated the impact of this flap on postoperative cancer surveillance.


Each patient receiving oncoplastic surgery with LD flap after partial mastectomy were matched in age, cancer stage, and body mass index with patients receiving partial mastectomy alone. Twenty-nine patients with the oncoplastic LD flap received 99 mammograms and 139 ultrasonograms, while 29 patients with partial mastectomy alone underwent 92 mammograms and 129 ultrasonograms. Mammographic and ultrasonographic findings were classified by Breast Imaging Reporting and Data System (BI-RADS) category and reviewed. Any recommendations for additional evaluation and recurrence were documented.


During an average follow-up period of 44 months, although the oncoplastic group demonstrated more newly developed benign calcifications (control 14% vs. oncoplastic 41%; p = 0.019) on mammography, the percentage of recall for additional imaging in category 0, and the short-interval follow-up in category 3, was not different between the control and oncoplastic group. Regarding ultrasonography, BI-RADS category was also not different between the two groups; however, the control group showed more fluid collections than the oncoplastic group (control 21% vs. oncoplastic 0%; p = 0.023). One case of local recurrence was observed in the control group.


Although there was an increase in benign calcifications in the oncoplastic group, there were no additional abnormal findings requiring further intervention. We concluded that the LD flap for oncoplastic surgery does not interfere with cancer surveillance, and even decreases the rate of fluid collection.



This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2018R1D1A1B07049448).


Kenneth L. Fan, Simon Yang, Seho Park, Tae Hwan Park, Seung Yong Song, Nara Lee, Dae Hyun Lew, Min Jung Kim, and Dong Won Lee have no conflicts of interest or financial ties to disclose.


  1. 1.
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9.PubMedGoogle Scholar
  4. 4.
    Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14(5):1558–64.PubMedGoogle Scholar
  5. 5.
    Blichert-Toft M, Nielsen M, During M, et al. Long-term results of breast conserving surgery versus mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol. 2008;47(4):672–81.PubMedGoogle Scholar
  6. 6.
    Simone NL, Dan T, Shih J, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Treat. 2012;132(1):197–203.PubMedGoogle Scholar
  7. 7.
    Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol. 2010;17(5):1375–91.PubMedGoogle Scholar
  8. 8.
    Clough KB, Ihrai T, Oden S, Kaufman G, Massey E, Nos C. Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas. Br J Surg. 2012;99(10):1389–95.PubMedGoogle Scholar
  9. 9.
    Losken A, Styblo TM, Carlson GW, Jones GE, Amerson BJ. Management algorithm and outcome evaluation of partial mastectomy defects treated using reduction or mastopexy techniques. Ann Plast Surg. 2007;59(3):235–42.PubMedGoogle Scholar
  10. 10.
    Hamdi M, Wolfli J, Van Landuyt K. Partial mastectomy reconstruction. Clin Plast Surg. 2007;34(1):51–62. (abstract vi).PubMedGoogle Scholar
  11. 11.
    Kronowitz SJ, Feledy JA, Hunt KK, et al. Determining the optimal approach to breast reconstruction after partial mastectomy. Plast Reconstr Surg. 2006;117(1):1–11. (discussion 12–14).PubMedGoogle Scholar
  12. 12.
    Kim KD, Kim Z, Kuk JC, et al. Long-term results of oncoplastic breast surgery with latissimus dorsi flap reconstruction: a pilot study of the objective cosmetic results and patient reported outcome. Ann Surg Treat Res. 2016;90(3):117–23.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Woerdeman LA, Hage JJ, Thio EA, Zoetmulder FA, Rutgers EJ. Breast-conserving therapy in patients with a relatively large (T2 or T3) breast cancer: long-term local control and cosmetic outcome of a feasibility study. Plast Reconstr Surg. 2004;113(6):1607–16.PubMedGoogle Scholar
  14. 14.
    Zoetmulder FA, Borger JH, Rutgers EJ, Bergman R, Peterse J, Bartelink H. Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation. Eur J Cancer. 1993;29A(7):957–61.Google Scholar
  15. 15.
    Hamdi M. Oncoplastic and reconstructive surgery of the breast. Breast. 2013;22 Suppl 2:S100–5.PubMedGoogle Scholar
  16. 16.
    Dixon JM, Venizelos B, Chan P. Latissimus dorsi mini-flap: a technique for extending breast conservation. Breast. 2002;11(1):58–65.PubMedGoogle Scholar
  17. 17.
    Kaur N, Petit JY, Rietjens M, et al. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol. 2005;12(7):539–45.PubMedGoogle Scholar
  18. 18.
    Losken A, Pinell-White X, Hart AM, Freitas AM, Carlson GW, Styblo TM. The oncoplastic reduction approach to breast conservation therapy: benefits for margin control. Aesthet Surg J. 2014;34(8):1185–91.PubMedGoogle Scholar
  19. 19.
    Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014;72(2):145–9.PubMedGoogle Scholar
  20. 20.
    Rietjens M, Urban CA, Rey PC, et al. Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast. 2007;16(4):387–95.PubMedGoogle Scholar
  21. 21.
    Mele S, Wright D, Paramanathan N, Laws S, Peiris L, Rainsbury R. Long-term effect of oncoplastic breast-conserving surgery using latissimus dorsi miniflaps on mammographic surveillance and the detection of local recurrence. J Plast Reconstr Aesthet Surg. 2017;70(9):1203–9.PubMedGoogle Scholar
  22. 22.
    Losken A, Schaefer TG, Newell M, Styblo TM. The impact of partial breast reconstruction using reduction techniques on postoperative cancer surveillance. Plast Reconstr Surg. 2009;124(1):9–17.PubMedGoogle Scholar
  23. 23.
    Dolan R, Patel M, Weiler-Mithoff E, et al. Imaging results following oncoplastic and standard breast conserving surgery. Breast Care (Basel). 2015;10(5):325–9.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med. 2001;23(4):292–300.PubMedGoogle Scholar
  25. 25.
    Saint-Cyr M, Nagarkar P, Schaverien M, Dauwe P, Wong C, Rohrich RJ. The pedicled descending branch muscle-sparing latissimus dorsi flap for breast reconstruction. Plast Reconstr Surg. 2009;123(1):13–24.PubMedGoogle Scholar
  26. 26.
    D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA, et al. ACR BI-RADS® Atlas, breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013.Google Scholar
  27. 27.
    Urban C, Lima R, Schunemann E, Spautz C, Rabinovich I, Anselmi K. Oncoplastic principles in breast conserving surgery. Breast. 2011;20 Suppl 3:S92–5.PubMedGoogle Scholar
  28. 28.
    Shin ES, Kim HI, Song SY, Lew DH, Lee DW. Selection of oncoplastic surgical technique in Asian breast cancer patients. Arch Plast Surg. 2018;45(1):37–44.PubMedGoogle Scholar
  29. 29.
    Piper M, Peled AW, Sbitany H, Foster RD, Esserman LJ, Price ER. Comparison of mammographic findings following oncoplastic mammoplasty and lumpectomy without reconstruction. Ann Surg Oncol. 2016;23(1):65–71.PubMedGoogle Scholar
  30. 30.
    Tan VK, Cornford EJ, McCulley SJ, Macmillan RD. Qualitative mammographic findings and outcomes of surveillance mammography after partial breast reconstruction with an autologous flap. J Surg Oncol. 2015;111(4):377–81.PubMedGoogle Scholar
  31. 31.
    Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.PubMedGoogle Scholar
  32. 32.
    Ramani SK, Rastogi A, Mahajan A, Nair N, Shet T, Thakur MH. Imaging of the treated breast post breast conservation surgery/oncoplasty: pictorial review. World J Radiol. 2017;9(8):321–9.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Mendelson EB. Evaluation of the postoperative breast. Radiol Clin North Am. 1992;30(1):107–38.PubMedGoogle Scholar
  34. 34.
    Monticciolo DL, Ross D, Bostwick J 3rd, Eaves F, Styblo T. Autologous breast reconstruction with endoscopic latissimus dorsi musculosubcutaneous flaps in patients choosing breast-conserving therapy: mammographic appearance. AJR Am J Roentgenol. 1996;167(2):385–9.PubMedGoogle Scholar
  35. 35.
    Margolis NE, Morley C, Lotfi P, et al. Update on imaging of the postsurgical breast. Radiographics. 2014;34(3):642–60.PubMedGoogle Scholar
  36. 36.
    del Carmen MG, Hughes KS, Halpern E, et al. Racial differences in mammographic breast density. Cancer. 2003;98(3):590–6.PubMedGoogle Scholar
  37. 37.
    Houssami N, Cho N. Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance. Ultrasonography. 2018;37(4):277–87.PubMedPubMedCentralGoogle Scholar
  38. 38.
    You JK, Song MK, Kim MJ, et al. Can biannual ultrasound surveillance detect smaller second cancers or detect cancers earlier in patients with breast cancer history? Ultrasound Med Biol. 2018;44(7):1355–63.PubMedGoogle Scholar
  39. 39.
    Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Cho N, Han W, Han BK, et al. Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol. 2017;3(11):1495–502.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Okada N, Narita Y, Takada M, et al. Early removal of drains and the incidence of seroma after breast surgery. Breast Cancer. 2015;22(1):79–83.PubMedGoogle Scholar
  42. 42.
    Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer. 2012;15(4):373–80.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Eroglu E, Oral S, Unal E, Kalayci M, Oksuz O, Tilmaz M. Reducing seroma formation with fibrin glue in an animal mastectomy model. Eur J Surg Oncol. 1996;22(2):137–9.PubMedGoogle Scholar
  44. 44.
    Coveney EC, O’Dwyer PJ, Geraghty JG, O’Higgins NJ. Effect of closing dead space on seroma formation after mastectomy: a prospective randomized clinical trial. Eur J Surg Oncol. 1993;19(2):143–6.PubMedGoogle Scholar
  45. 45.
    Gong Y, Xu J, Shao J, et al. Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: a randomized trial. Am J Surg. 2010;200(3):352–6.PubMedGoogle Scholar
  46. 46.
    Jain PK, Sowdi R, Anderson AD, MacFie J. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg. 2004;91(1):54–60.PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Plastic and Reconstructive SurgeryMedStar Georgetown University HospitalWashingtonUSA
  2. 2.Department of Plastic and Reconstructive Surgery, and Institute for Human Tissue RestorationYonsei University College of MedicineSeoulKorea
  3. 3.Division of Breast Surgery, Department of SurgeryYonsei University College of MedicineSeoulKorea
  4. 4.Division of Public Health Sciences, Department of SurgeryWashington University School of MedicineSt. LouisUSA
  5. 5.Department of Plastic and Reconstructive SurgeryCHA Bundang Medical Center, CHA UniversitySeongnamKorea
  6. 6.Department of Radiology, Research Institute of Radiologic ScienceYonsei University College of MedicineSeoulKorea

Personalised recommendations